TTR and Parkinson disease: We propose that a stabilization of physiological aggregation-resistant αSH in PD and DLB patients may be beneficial in slowing down the process of neurodegeneration, analogous to efforts currently underway toward stabilizing transthyretin in familial amyloid polyneuropathy [11, 41].